Regular marijuana users are less likely to be obese than people who don’t consume cannabis, according to a new study. In fact, the analysis showed a “dose-response relationship between marijuana use and [body mass index], with the lower the BMI classification, the higher marijuana use.” People who’d used cannabis within the past month were “31%
Ohio adult-use marijuana sales reached $22.5 million in the first 11 days since the market launched earlier this month, according to new data from the Division of Cannabis Control (DCC). After selling $11.5 million in recreational marijuana during the first five days of the state’s first hybrid dispensaries opening, the state saw another $10.9 million
Americans view marijuana as less harmful than alcohol, tobacco and nicotine vapes—and more adults now smoke cannabis than smoke cigarettes—according to a new Gallup poll. While respondents were largely divided over whether cannabis generally has a positive or negative effect on society and consumers, marijuana ranked lowest in terms of perceived harmfulness out of a
“Democrats, Republicans, Libertarians—they want to see this fully legalized. It’s been held hostage with the political back-and-forth rhetoric.” By Tim Carpenter, Kansas Reflector Inga Selders watched the Kansas Legislature repeatedly fumble bills opening the door to legal sales of medicinal or recreational cannabis. The U.S. Congress has declined to bring unity to the hodgepodge of
First dibs on cannabis licenses go to those who can prove what the state law terms social equity status. By Peter Callaghan, MinnPost Military veterans and those with prior marijuana convictions make up the largest number of those qualifying for social equity status ahead of getting into the business under Minnesota’s legal cannabis law. As
A federal appeals panel heard oral arguments Monday in the case of a Washington State doctor seeking to legally use psilocybin to treat cancer patients in end-of-life care. The lawsuit from Dr. Sunil Aggarwal and his clinic, the Advanced Integrated Medical Science (AIMS) Institute, centers on whether the federal government must allow certain patients access